![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
9MB |
![[thumbnail of Supplemental Information]](https://mdc-test.eprints-hosting.org/style/images/fileicons/other.png) |
Other (Supplemental Information)
13MB |
| Item Type: | Article |
|---|---|
| Title: | Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities |
| Creators Name: | Vasaikar, S., Huang, C., Wang, X., Petyuk, V.A., Savage, S.R., Wen, B., Dou, Y., Zhang, Y., Shi, Z., Arshad, O.A., Gritsenko, M.A., Zimmerman, L.J., McDermott, J.E., Clauss, T.R., Moore, R.J., Zhao, R., Monroe, M.E., Wang, Y.T., Chambers, M.C., Slebos, R.J.C., Lau, K.S., Mo, Q., Ding, L., Ellis, M., Thiagarajan, M., Kinsinger, C.R., Rodriguez, H., Smith, R.D., Rodland, K.D., Liebler, D.C., Liu, T. and Zhang, B. |
| Abstract: | We performed the first proteogenomic study on a prospectively collected colon cancer cohort. Comparative proteomic and phosphoproteomic analysis of paired tumor and normal adjacent tissues produced a catalog of colon cancer-associated proteins and phosphosites, including known and putative new biomarkers, drug targets, and cancer/testis antigens. Proteogenomic integration not only prioritized genomically inferred targets, such as copy-number drivers and mutation-derived neoantigens, but also yielded novel findings. Phosphoproteomics data associated Rb phosphorylation with increased proliferation and decreased apoptosis in colon cancer, which explains why this classical tumor suppressor is amplified in colon tumors and suggests a rationale for targeting Rb phosphorylation in colon cancer. Proteomics identified an association between decreased CD8 T cell infiltration and increased glycolysis in microsatellite instability-high (MSI-H) tumors, suggesting glycolysis as a potential target to overcome the resistance of MSI-H tumors to immune checkpoint blockade. Proteogenomics presents new avenues for biological discoveries and therapeutic development. |
| Keywords: | Colon Cancer, Proteomics, Proteogenomics, Tumor Antigen, Immune Evasion, Glycolysis, Drug Targets, Biomarkers, RB1, SOX9 |
| Source: | Cell |
| ISSN: | 0092-8674 |
| Publisher: | Cell Press |
| Volume: | 177 |
| Number: | 4 |
| Page Range: | 1035-1049 |
| Date: | 2 May 2019 |
| Additional Information: | Philipp Mertins is a member of the Clinical Proteomic Tumor Analysis Consortium. |
| Official Publication: | https://doi.org/10.1016/j.cell.2019.03.030 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
